Handa Pharmaceuticals, Inc. (TPEX:6620)

Handa Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	19,842	10,576	25,891	16,074	8,451	2,820
Market Cap Growth	98.64%	-59.15%	61.07%	90.20%	199.72%	-18.91%
Enterprise Value	17,045	8,085	23,747	15,869	8,249	2,326
Last Close Price	126.50	73.58	179.00	118.61	65.86	23.12
PE Ratio	29.88	22.37	35.62	-	-	-
PS Ratio	14.83	12.73	23.40	81.32	289.08	97.71
PB Ratio	4.70	3.39	9.39	22.29	18.25	5.23
P/TBV Ratio	5.77	4.89	9.52	23.46	19.80	5.59
P/FCF Ratio	83.84	21.59	38.79	-	-	-
P/OCF Ratio	78.66	21.25	38.74	-	-	-
EV/Sales Ratio	12.74	9.73	21.47	80.28	282.15	80.61
EV/EBITDA Ratio	21.80	19.20	34.00	-	-	-
EV/EBIT Ratio	22.18	19.34	34.25	-	-	-
EV/FCF Ratio	72.02	16.51	35.58	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.04	0.03	0.03
Debt / EBITDA Ratio	0.06	0.09	0.02	-	-	-
Debt / FCF Ratio	0.21	0.08	0.02	-	-	-
Asset Turnover	0.34	0.26	0.58	0.31	0.05	0.04
Quick Ratio	9.13	8.49	12.89	11.63	10.05	9.05
Current Ratio	9.17	8.72	12.96	13.07	10.57	10.79
Return on Equity (ROE)	17.42%	16.10%	41.81%	-6.76%	-49.43%	-41.47%
Return on Assets (ROA)	12.36%	8.07%	22.64%	-8.54%	-29.36%	-27.20%
Return on Capital (ROIC)	13.40%	8.82%	24.62%	-8.99%	-30.89%	-28.46%
Return on Capital Employed (ROCE)	18.00%	13.10%	24.50%	-	-	-
Earnings Yield	3.13%	4.47%	2.81%	-0.25%	-2.93%	-10.00%
FCF Yield	1.19%	4.63%	2.58%	-1.32%	-2.19%	-11.20%
Dividend Yield	1.19%	2.04%	0.56%	-	-	-
Payout Ratio	-	29.84%	-	-	-	-
Buyback Yield / Dilution	-4.72%	-4.73%	-7.29%	-6.65%	-1.87%	-5.35%
Total Shareholder Return	-3.53%	-2.69%	-6.73%	-6.65%	-1.87%	-5.35%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.